Abstract: [Problem] To provide: an anti human NGF antibody which is reduced in the influence on fetuses and the risk of adverse side effects including thrombosis while keeping a high neutralizing activity and which has excellent safety or an antigen binding fragment thereof; and a means for preventing or treating various diseases for which human NGF is involved in the development of a disease state which utilizes the antibody or an antigen binding fragment thereof. [Solution] An Fab fragment of an anti human NGF antibody which comprises a heavy chain variable region comprising the amino acid sequence represented by SEQ ID NO: 6 and a light chain variable region comprising the amino acid sequence represented by SEQ ID NO: 4.
[Claim 1] An anti-human NGF antibody Fab5 fragment comprising:
a heavy-chain variable region consisting of an amino acid sequence shown by SEQ
IDNO:6;and
a light-chain variable region consisting of an amino acid sequence shown by SEQ
IDNO:4.
[Claim 2] The Fab' fragment according to Claim 1, wherein a heavy-chain constant
region of the Fab5 fragment is a human Igyl constant region.
[Claim 3] The Fab5 fragment according to Claim 1, wherein a light-chain constant
region of the Fab' fragment is a human IgK constant region.
[Claim 4] The Fab' fragment according to Claim 1, wherein the heavy-chain
constant region of the Fab' fragment is the human Igyl constant region, and the light-chain constant region of the Fab3 fragment is the human IgK constant region.
[Claim 5] The Fab' fragment according to Claim 1, comprising;
a heavy-chain fragment consisting of an amino acid sequence shown by SEQ ID NO:10, SEQ ID NO:14, or SEQ ID NO:16; and
a light chain consisting of an amino acid sequence shown by SEQ ID NO: 12.
[Claim 6] The Fab' fragment according to any one of Claims I to 5, wherein the Fab'
fragment is conjugated to polyethylene glycol
[Claim 7] A polynucleotide comprising a sequence that encodes the heavy-chain
fragment of the Fab' fragment according to Claim 1.
[Claim 8] A polynucleotide comprising a sequence that encodes the light chain of
the Fab' fragment according to Claim 1.
[Claim 9] An expression vector comprising the polynucleotide according to Claim 7
and/or Claim 8=
[Claim 10] A host cell transformed with the expression vector according to Claim 9.
[Claim 11] The host cell according to Claim 105 which is selected from a group
consisting of the following (a) and (b)s
(a) a host cell transformed with an expression vector comprising a polynucleotide comprising a sequence that encodes the heavy-chain fragment of the Fab' fragment according to Claim 1 and a polynucleotide comprising sequence that encodes the light chain of the Fab3 fragment; and
(b) a host cell transformed with an expression vector comprising a polynucleotide comprising a sequence that encodes the heavy-chain fragment of the Fab' fragment according to Claim 1 and with an expression vector comprising a polynucleotide comprising a sequence that encodes the light chain of the Fab' fragment.
[Claim 12] Amethodof producing the anti-human NGF antibody Fab5 fragment according to Claim 1, comprising expressing an anti-human NGF antibody Fab' fragment by culturing the host cell according to Claim 10 or 11.
| # | Name | Date |
|---|---|---|
| 1 | 614-CHENP-2014-Abstract_Granted 340768_07-07-2020.pdf | 2020-07-07 |
| 1 | Y04-305461-IN_sequence listing.txt | 2014-02-05 |
| 2 | 614-CHENP-2014-Claims_Granted 340768_07-07-2020.pdf | 2020-07-07 |
| 2 | GPA.pdf | 2014-02-05 |
| 3 | F5.pdf | 2014-02-05 |
| 3 | 614-CHENP-2014-Description_Granted 340768_07-07-2020.pdf | 2020-07-07 |
| 4 | F3.pdf | 2014-02-05 |
| 4 | 614-CHENP-2014-Drawings_Granted 340768_07-07-2020.pdf | 2020-07-07 |
| 5 | 614-CHENP-2014.pdf | 2014-02-05 |
| 5 | 614-CHENP-2014-IntimationOfGrant07-07-2020.pdf | 2020-07-07 |
| 6 | 614-CHENP-2014-Marked up Claims_Granted 340768_07-07-2020.pdf | 2020-07-07 |
| 6 | 262-2014-COMPLETE SPECIFICATION.pdf | 2014-02-05 |
| 7 | 614-CHENP-2014-PatentCertificate07-07-2020.pdf | 2020-07-07 |
| 7 | 614-CHENP-2014 FORM-3 07-07-2014.pdf | 2014-07-07 |
| 8 | 614-CHENP-2014-2. Marked Copy under Rule 14(2) [30-06-2020(online)].pdf | 2020-06-30 |
| 8 | 614-CHENP-2014 FORM-1 07-07-2014.pdf | 2014-07-07 |
| 9 | 614-CHENP-2014 CORRESPONDENCE OTHERS 07-07-2014.pdf | 2014-07-07 |
| 9 | 614-CHENP-2014-Response to office action [30-06-2020(online)].pdf | 2020-06-30 |
| 10 | 614-CHENP-2014 FORM-13 16-09-2014.pdf | 2014-09-16 |
| 10 | 614-CHENP-2014-Retyped Pages under Rule 14(1) [30-06-2020(online)].pdf | 2020-06-30 |
| 11 | 614-CHENP-2014 OTHER PATENT DOCUMENT 16-09-2014.pdf | 2014-09-16 |
| 11 | 614-CHENP-2014-certified copy of translation (MANDATORY) [04-03-2019(online)].pdf | 2019-03-04 |
| 12 | 614-CHENP-2014-CLAIMS [04-03-2019(online)].pdf | 2019-03-04 |
| 12 | 614-P-2014 (Marked up copy of claims).pdf | 2014-09-26 |
| 13 | 614-CHENP-2014-COMPLETE SPECIFICATION [04-03-2019(online)].pdf | 2019-03-04 |
| 13 | 614-P-2014 (Form 13).pdf | 2014-09-26 |
| 14 | 614-CHENP-2014-FER_SER_REPLY [04-03-2019(online)].pdf | 2019-03-04 |
| 14 | 614-P-2014 (Amended claims).pdf | 2014-09-26 |
| 15 | 614-CHENP-2014 FORM-3 28-05-2015.pdf | 2015-05-28 |
| 15 | 614-CHENP-2014-FORM 3 [04-03-2019(online)].pdf | 2019-03-04 |
| 16 | 614-CHENP-2014 CORRESPONDENCE OTHERS 28-05-2015.pdf | 2015-05-28 |
| 16 | 614-CHENP-2014-OTHERS [04-03-2019(online)].pdf | 2019-03-04 |
| 17 | Form 3 [12-06-2017(online)].pdf | 2017-06-12 |
| 17 | 614-CHENP-2014-PETITION UNDER RULE 137 [04-03-2019(online)]-1.pdf | 2019-03-04 |
| 18 | 614-CHENP-2014-FER.pdf | 2018-09-06 |
| 18 | 614-CHENP-2014-PETITION UNDER RULE 137 [04-03-2019(online)].pdf | 2019-03-04 |
| 19 | 614-CHENP-2014-certified copy of translation (MANDATORY) [16-11-2018(online)].pdf | 2018-11-16 |
| 19 | Correspondence by Agent_Power of Attorney_26-12-2018.pdf | 2018-12-26 |
| 20 | 614-CHENP-2014-FORM-26 [14-12-2018(online)].pdf | 2018-12-14 |
| 21 | 614-CHENP-2014-certified copy of translation (MANDATORY) [16-11-2018(online)].pdf | 2018-11-16 |
| 21 | Correspondence by Agent_Power of Attorney_26-12-2018.pdf | 2018-12-26 |
| 22 | 614-CHENP-2014-FER.pdf | 2018-09-06 |
| 22 | 614-CHENP-2014-PETITION UNDER RULE 137 [04-03-2019(online)].pdf | 2019-03-04 |
| 23 | 614-CHENP-2014-PETITION UNDER RULE 137 [04-03-2019(online)]-1.pdf | 2019-03-04 |
| 23 | Form 3 [12-06-2017(online)].pdf | 2017-06-12 |
| 24 | 614-CHENP-2014-OTHERS [04-03-2019(online)].pdf | 2019-03-04 |
| 24 | 614-CHENP-2014 CORRESPONDENCE OTHERS 28-05-2015.pdf | 2015-05-28 |
| 25 | 614-CHENP-2014-FORM 3 [04-03-2019(online)].pdf | 2019-03-04 |
| 25 | 614-CHENP-2014 FORM-3 28-05-2015.pdf | 2015-05-28 |
| 26 | 614-CHENP-2014-FER_SER_REPLY [04-03-2019(online)].pdf | 2019-03-04 |
| 26 | 614-P-2014 (Amended claims).pdf | 2014-09-26 |
| 27 | 614-CHENP-2014-COMPLETE SPECIFICATION [04-03-2019(online)].pdf | 2019-03-04 |
| 27 | 614-P-2014 (Form 13).pdf | 2014-09-26 |
| 28 | 614-CHENP-2014-CLAIMS [04-03-2019(online)].pdf | 2019-03-04 |
| 28 | 614-P-2014 (Marked up copy of claims).pdf | 2014-09-26 |
| 29 | 614-CHENP-2014 OTHER PATENT DOCUMENT 16-09-2014.pdf | 2014-09-16 |
| 29 | 614-CHENP-2014-certified copy of translation (MANDATORY) [04-03-2019(online)].pdf | 2019-03-04 |
| 30 | 614-CHENP-2014 FORM-13 16-09-2014.pdf | 2014-09-16 |
| 30 | 614-CHENP-2014-Retyped Pages under Rule 14(1) [30-06-2020(online)].pdf | 2020-06-30 |
| 31 | 614-CHENP-2014 CORRESPONDENCE OTHERS 07-07-2014.pdf | 2014-07-07 |
| 31 | 614-CHENP-2014-Response to office action [30-06-2020(online)].pdf | 2020-06-30 |
| 32 | 614-CHENP-2014 FORM-1 07-07-2014.pdf | 2014-07-07 |
| 32 | 614-CHENP-2014-2. Marked Copy under Rule 14(2) [30-06-2020(online)].pdf | 2020-06-30 |
| 33 | 614-CHENP-2014 FORM-3 07-07-2014.pdf | 2014-07-07 |
| 33 | 614-CHENP-2014-PatentCertificate07-07-2020.pdf | 2020-07-07 |
| 34 | 262-2014-COMPLETE SPECIFICATION.pdf | 2014-02-05 |
| 34 | 614-CHENP-2014-Marked up Claims_Granted 340768_07-07-2020.pdf | 2020-07-07 |
| 35 | 614-CHENP-2014-IntimationOfGrant07-07-2020.pdf | 2020-07-07 |
| 35 | 614-CHENP-2014.pdf | 2014-02-05 |
| 36 | 614-CHENP-2014-Drawings_Granted 340768_07-07-2020.pdf | 2020-07-07 |
| 36 | F3.pdf | 2014-02-05 |
| 37 | F5.pdf | 2014-02-05 |
| 37 | 614-CHENP-2014-Description_Granted 340768_07-07-2020.pdf | 2020-07-07 |
| 38 | GPA.pdf | 2014-02-05 |
| 38 | 614-CHENP-2014-Claims_Granted 340768_07-07-2020.pdf | 2020-07-07 |
| 39 | Y04-305461-IN_sequence listing.txt | 2014-02-05 |
| 39 | 614-CHENP-2014-Abstract_Granted 340768_07-07-2020.pdf | 2020-07-07 |
| 1 | Captured_20-08-2018.pdf |